Brean Murray Downgrades Dendreon To Sell, $6 PT

August 4, 2011 8:02 AM | 7 seconds read |
Brean Murray Carret & Company has downgraded Dendreon DNDN to Sell and has lowered the price target to $6.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: DowngradesPrice TargetAnalyst RatingsBiotechnologyBrean Murray Carret & CompanyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!